PBA
Paradigm Biocapital Advisors’s Nuvalent NUVL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402M | Hold |
5,269,433
| – | – | 17.17% | 1 |
|
|
2025
Q1 | $374M | Sell |
5,269,433
-93,946
| -2% | -$6.66M | 17.12% | 1 |
|
|
2024
Q4 | $420M | Buy |
5,363,379
+363,379
| +7% | +$28.4M | 14.61% | 1 |
|
|
2024
Q3 | $512M | Buy |
5,000,000
+428,322
| +9% | +$43.8M | 17.3% | 1 |
|
|
2024
Q2 | $347M | Buy |
4,571,678
+393,848
| +9% | +$29.9M | 13.27% | 1 |
|
|
2024
Q1 | $314M | Buy |
4,177,830
+319,822
| +8% | +$24M | 11.04% | 1 |
|
|
2023
Q4 | $284M | Buy |
3,858,008
+2,219,861
| +136% | +$163M | 13.29% | 1 |
|
|
2023
Q3 | $75.3M | Buy |
1,638,147
+517,682
| +46% | +$23.8M | 5.11% | 5 |
|
|
2023
Q2 | $47.3M | Buy |
+1,120,465
| New | +$47.3M | 3.65% | 13 |
|